Viewing nowDapoura Tablet 5 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.

MFDS item code 202300305 · Approved 2023.01.19 · Insurance code 628801730
Treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease
This medicine is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. Additionally, it is used together with other treatments in patients with chronic heart failure to reduce the risk of death and hospitalization due to cardiovascular diseases. It is also used in patients with chronic kidney disease to reduce the worsening of kidney function and the risk of cardiovascular diseases. This medicine helps not only in managing blood sugar but also in lowering the risk of complications related to cardiovascular and kidney health. Therefore, it is effectively used for the management of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other antihyperglycemic agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy When administered in combination with metformin to patients with no previous history of antidiabetic drug treatment, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medicine should not be used in patients who are allergic to its active ingredients or additives. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medicine contains lactose, so it should not be used in patients with genetic issues such as galactose intolerance, lactose deficiency, or glucose-galactose malabsorption. Patients on dialysis should not take this medicine. Patients with decreased fluid volume or kidney function impairment must use this medicine with caution, ensuring fluid status and kidney function are assessed prior to use. This medicine can lower blood pressure, so elderly patients with symptomatic hypotension or those taking diuretics, as well as patients with impaired kidney function, should be cautious. For patients with diabetes who have moderately or severely impaired kidney function, blood sugar control may be less effective. Taking this medicine may cause adverse reactions such as genital infections, urinary tract infections, decreased fluid volume, hypoglycemia, diabetic ketoacidosis, so it is important to monitor symptoms carefully. Especially in women, genital infections occur more frequently, and patients with a history of infections are at higher risk of recurrence. Even if blood sugar levels are low, ketoacidosis can occur, so if symptoms such as dehydration, vomiting, abdominal pain, lethargy, or difficulty breathing occur, medical attention should be sought immediately. There is an increased risk of hypoglycemia when this medicine is used in combination with blood sugar-lowering agents such as insulin or sulfonylureas, so dosage adjustments may be necessary. Elderly patients, those with liver disease, and patients with low blood pressure should take extra caution when using this medicine, and fluid status should be monitored frequently. Women who are pregnant or breastfeeding should not use this medicine, and it should be discontinued immediately if pregnancy is confirmed. The safety and efficacy of this medicine in pediatric patients have not been established, so it is advisable not to use it. In cases of overdose, there are no specific antidotes, and appropriate treatment should be administered according to symptoms, with observation and treatment in medical facilities as necessary. During the use of this medicine, caution should be taken while driving or operating machinery due to the risk of hypoglycemia. Finally, this medicine should be kept out of reach of children and stored in its original container to maintain quality.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, fluid volume depletion, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, increased hematocrit, decreased initial renal creatinine clearance during treatment, dyslipidemia, increased serum creatinine levels during initial treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulitis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, urinary abnormalities, increased blood lactate, lymphocytopenia, weight gain, vitamin D deficiency, increased appetite, dysgeusia, drowsiness, tension-type headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, unconsciousness, nerve compression, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, diverticulitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like illness, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital swelling, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to ensure the medicine's effects are preserved safely for a long time.
Yellow, biconvex, round, film-coated tablet
100 tablets/bottle, 30 tablets/bottle, 28 tablets (14 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.